Clinical Trial Details
| Trial ID: | L0336 |
| Source ID: | NCT00234702 |
| Associated Drug: | Lanthanum Carbonate |
| Title: | Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Kidney Diseases |
| Interventions: | DRUG: Lanthanum carbonate|DRUG: Placebo |
| Outcome Measures: | Primary: Serum phosphorus levels at 8 weeks., 8 weeks | Secondary: PTH levels, calcium-phosphorus product., 8 weeks |
| Sponsor/Collaborators: | Sponsor: Shire |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 84 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2006-01-11 |
| Completion Date: | 2007-06-01 |
| Results First Posted: | |
| Last Update Posted: | 2021-06-08 |
| Locations: | VA Greater Los Angeles Health Care System, Los Angeles, California, 90073, United States|Barnett Research & Communications Medical Corporation, Torrance, California, 90503, United States|Western Nephrology & Metabolic Bone Disease, PC, Thornton, Colorado, 80260, United States|Outcomes Research International, Inc., Hudson, Florida, 34667, United States|Twin Cities Clinical Research, Brooklyn Center, Minnesota, 55430, United States|St. Louis University/Nephrology, Saint Louis, Missouri, 63110, United States|University of North Carolina, Chapel Hill, North Carolina, 27599, United States|Northwest Renal Clinic, Portland, Oregon, 97210, United States|Nephrology Associates, Nashville, Tennessee, United States|Kidney Associates, Houston, Texas, 77030, United States |
| URL: | https://clinicaltrials.gov/show/NCT00234702 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|